- Home
- CISS vs PALI Comparison
CISS vs PALI Comparison
Compare CISS & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISS
- PALI
- Stock Information
- Founded
- CISS 2022
- PALI 1996
- Country
- CISS Greece
- PALI United States
- Employees
- CISS N/A
- PALI N/A
- Industry
- CISS Marine Transportation
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CISS Consumer Discretionary
- PALI Health Care
- Exchange
- CISS Nasdaq
- PALI Nasdaq
- Market Cap
- CISS 3.0M
- PALI 3.1M
- IPO Year
- CISS N/A
- PALI N/A
- Fundamental
- Price
- CISS $0.58
- PALI $0.64
- Analyst Decision
- CISS
- PALI Strong Buy
- Analyst Count
- CISS 0
- PALI 2
- Target Price
- CISS N/A
- PALI $23.00
- AVG Volume (30 Days)
- CISS 80.0K
- PALI 701.7K
- Earning Date
- CISS 05-27-2025
- PALI 03-24-2025
- Dividend Yield
- CISS N/A
- PALI N/A
- EPS Growth
- CISS N/A
- PALI N/A
- EPS
- CISS N/A
- PALI N/A
- Revenue
- CISS $42,296,101.00
- PALI N/A
- Revenue This Year
- CISS N/A
- PALI N/A
- Revenue Next Year
- CISS N/A
- PALI N/A
- P/E Ratio
- CISS N/A
- PALI N/A
- Revenue Growth
- CISS 47.17
- PALI N/A
- 52 Week Low
- CISS $0.48
- PALI $0.64
- 52 Week High
- CISS $13.50
- PALI $9.65
- Technical
- Relative Strength Index (RSI)
- CISS 30.12
- PALI 29.80
- Support Level
- CISS $0.48
- PALI $0.65
- Resistance Level
- CISS $0.74
- PALI $0.73
- Average True Range (ATR)
- CISS 0.05
- PALI 0.06
- MACD
- CISS 0.00
- PALI 0.00
- Stochastic Oscillator
- CISS 37.27
- PALI 1.18
About CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.